Genome-Wide Gene Expression Analyses of <i>BRCA1</i>- and <i>BRCA2</i>-Associated Breast and Ovarian Tumours

Germline pathogenic variants in <i>BRCA1</i> and <i>BRCA2</i> increase cumulative lifetime risk up to 75% for breast cancer and 76% for ovarian cancer. Genetic testing for <i>BRCA1</i> and <i>BRCA2</i> pathogenic variants has become an important part o...

Full description

Bibliographic Details
Main Authors: George A. R. Wiggins, Logan C. Walker, John F. Pearson
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/10/3015